Amgen – Anti-inflammatory Therapeutics Market Growth Analysis,Size,Insight,Share And Outlook By 2027AbbVie, Johnson & Johnson, Amgen Inc – NeighborWebSJ
Anti-inflammatory therapeutics are treatments for arthritis, respiratory diseases, dermatology, psoriasis, inflammatory bowel disease and other inflammatory diseases. The treatments include anti-inflammatory biologics, NSAIDs, corticosteroids and others. Top 5 manufacturers make up the major market share in the anti-inflammatory therapeutics market. AbbVie maintained its first place in the ranking in 2019, accounted for 21.59% market share. Other players accounted for 14.20%, 5.43%, 5.32% including Johnson & Johnson, Amgen Inc, AstraZeneca PLC.
Market Analysis and Insights:
Global Anti-inflammatory Therapeutics Market The global Anti-inflammatory Therapeutics market size is projected to reach US$ 148620 million by 2026, from US$ 98030 million in 2019, at a CAGR of 6.1% during 2021-2026.
Get Sample Copy of This Report @
https://www.qyresearch.com/sample-form/form/2626477/global-anti-inflammatory-therapeutics-market
:
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Anti-inflammatory Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Anti-inflammatory Therapeutics market in terms of revenue. On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Anti-inflammatory Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Anti-inflammatory Therapeutics market.
Anti-inflammatory Therapeutics Breakdown Data by Type
Anti-inflammatory Biologics, Non-Steroidal Anti-inflammatory Drugs (NSAIDs), Corticosteroids, Others, On the basis of product type, anti-inflammatory biologics segment is projected to account for the largest revenue share during the forecast period; this segment was estimated to account for 58.35% revenue share in 2019, at a cagr of 6.54% in the forecast period.
Anti-inflammatory Therapeutics Breakdown Data by Application
Arthritis, Respiratory Diseases, Dermatology, Gastroenterology, Others, Arthritis accounted for over 42.41% global revenue share in 2019. And it is also show a fast growth rate of 6.60% in the next few years from 2020 to 2026. Based on regional and country-level analysis,
the Anti-inflammatory Therapeutics market has been segmented as follows:,
North America, United States, Canada, Europe, Germany, France, UK., Italy, Russia, Nordic, Rest of Europe, Asia-Pacific, China, Japan, South Korea, Southeast Asia, India, Australia, Rest of Asia-Pacific, Latin America, Mexico, Brazil, Middle East & Africa, Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa In the competitive analysis section of the report, leading as well as prominent players of the global Anti-inflammatory Therapeutics market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2016-2021.
The following players are covered in this report:
, AbbVie, Johnson & Johnson, Amgen Inc, AstraZeneca PLC, Pfizer, Inc, Novartis, Roche, Merck, Sanofi, AstraZeneca PLC, Pfizer, Inc, TEVA
Get Full Report In Your Inbox Within 24 Hours at USD(3900):
https://www.https://www.qyresearch.com/settlement/pre/6e4544ace7279bbe2f7a64aed4dea791,0,1,global-anti-inflammatory-therapeutics-market
Table of Contents
1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type
1.2.1 Global Anti-inflammatory Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Anti-inflammatory Biologics
1.2.3 Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
1.2.4 Corticosteroids
1.2.5 Others 1.3 Market by Application
1.3.1 Global Anti-inflammatory Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Arthritis
1.3.3 Respiratory Diseases
1.3.4 Dermatology
1.3.5 Gastroenterology
1.3.6 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Anti-inflammatory Therapeutics Market Perspective (2016-2027) 2.2 Anti-inflammatory Therapeutics Growth Trends by Regions
2.2.1 Anti-inflammatory Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Anti-inflammatory Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Anti-inflammatory Therapeutics Forecasted Market Size by Regions (2022-2027) 2.3 Anti-inflammatory Therapeutics Industry Dynamic
2.3.1 Anti-inflammatory Therapeutics Market Trends
2.3.2 Anti-inflammatory Therapeutics Market Drivers
2.3.3 Anti-inflammatory Therapeutics Market Challenges
2.3.4 Anti-inflammatory Therapeutics Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Anti-inflammatory Therapeutics Players by Revenue
3.1.1 Global Top Anti-inflammatory Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Anti-inflammatory Therapeutics Revenue Market Share by Players (2016-2021) 3.2 Global Anti-inflammatory Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Anti-inflammatory Therapeutics Revenue 3.4 Global Anti-inflammatory Therapeutics Market Concentration Ratio
3.4.1 Global Anti-inflammatory Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-inflammatory Therapeutics Revenue in 2020 3.5 Anti-inflammatory Therapeutics Key Players Head office and Area Served 3.6 Key Players Anti-inflammatory Therapeutics Product Solution and Service 3.7 Date of Enter into Anti-inflammatory Therapeutics Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Anti-inflammatory Therapeutics Breakdown Data by Type 4.1 Global Anti-inflammatory Therapeutics Historic Market Size by Type (2016-2021) 4.2 Global Anti-inflammatory Therapeutics Forecasted Market Size by Type (2022-2027) 5 Anti-inflammatory Therapeutics Breakdown Data by Application 5.1 Global Anti-inflammatory Therapeutics Historic Market Size by Application (2016-2021) 5.2 Global Anti-inflammatory Therapeutics Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Anti-inflammatory Therapeutics Market Size (2016-2027) 6.2 North America Anti-inflammatory Therapeutics Market Size by Type
6.2.1 North America Anti-inflammatory Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Anti-inflammatory Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Anti-inflammatory Therapeutics Market Size by Type (2016-2027) 6.3 North America Anti-inflammatory Therapeutics Market Size by Application
6.3.1 North America Anti-inflammatory Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Anti-inflammatory Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Anti-inflammatory Therapeutics Market Size by Application (2016-2027) 6.4 North America Anti-inflammatory Therapeutics Market Size by Country
6.4.1 North America Anti-inflammatory Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Anti-inflammatory Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada 7 Europe 7.1 Europe Anti-inflammatory Therapeutics Market Size (2016-2027) 7.2 Europe Anti-inflammatory Therapeutics Market Size by Type
7.2.1 Europe Anti-inflammatory Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Anti-inflammatory Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Anti-inflammatory Therapeutics Market Size by Type (2016-2027) 7.3 Europe Anti-inflammatory Therapeutics Market Size by Application
7.3.1 Europe Anti-inflammatory Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Anti-inflammatory Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Anti-inflammatory Therapeutics Market Size by Application (2016-2027) 7.4 Europe Anti-inflammatory Therapeutics Market Size by Country
7.4.1 Europe Anti-inflammatory Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Anti-inflammatory Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 UK.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Anti-inflammatory Therapeutics Market Size (2016-2027) 8.2 Asia-Pacific Anti-inflammatory Therapeutics Market Size by Type
8.2.1 Asia-Pacific Anti-inflammatory Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Anti-inflammatory Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Anti-inflammatory Therapeutics Market Size by Type (2016-2027) 8.3 Asia-Pacific Anti-inflammatory Therapeutics Market Size by Application
8.3.1 Asia-Pacific Anti-inflammatory Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Anti-inflammatory Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Anti-inflammatory Therapeutics Market Size by Application (2016-2027) 8.4 Asia-Pacific Anti-inflammatory Therapeutics Market Size by Region
8.4.1 Asia-Pacific Anti-inflammatory Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Anti-inflammatory Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia 9 Latin America 9.1 Latin America Anti-inflammatory Therapeutics Market Size (2016-2027) 9.2 Latin America Anti-inflammatory Therapeutics Market Size by Type
9.2.1 Latin America Anti-inflammatory Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Anti-inflammatory Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Anti-inflammatory Therapeutics Market Size by Type (2016-2027) 9.3 Latin America Anti-inflammatory Therapeutics Market Size by Application
9.3.1 Latin America Anti-inflammatory Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Anti-inflammatory Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Anti-inflammatory Therapeutics Market Size by Application (2016-2027) 9.4 Latin America Anti-inflammatory Therapeutics Market Size by Country
9.4.1 Latin America Anti-inflammatory Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Anti-inflammatory Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Anti-inflammatory Therapeutics Market Size (2016-2027) 10.2 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Type
10.2.1 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Type (2016-2027) 10.3 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Application
10.3.1 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Application (2016-2027) 10.4 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Country
10.4.1 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE 11 Key Players Profiles 11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Anti-inflammatory Therapeutics Introduction
11.1.4 AbbVie Revenue in Anti-inflammatory Therapeutics Business (2016-2021)
11.1.5 AbbVie Recent Development 11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Anti-inflammatory Therapeutics Introduction
11.2.4 Johnson & Johnson Revenue in Anti-inflammatory Therapeutics Business (2016-2021)
11.2.5 Johnson & Johnson Recent Development 11.3 Amgen Inc
11.3.1 Amgen Inc Company Details
11.3.2 Amgen Inc Business Overview
11.3.3 Amgen Inc Anti-inflammatory Therapeutics Introduction
11.3.4 Amgen Inc Revenue in Anti-inflammatory Therapeutics Business (2016-2021)
11.3.5 Amgen Inc Recent Development 11.4 AstraZeneca PLC
11.4.1 AstraZeneca PLC Company Details
11.4.2 AstraZeneca PLC Business Overview
11.4.3 AstraZeneca PLC Anti-inflammatory Therapeutics Introduction
11.4.4 AstraZeneca PLC Revenue in Anti-inflammatory Therapeutics Business (2016-2021)
11.4.5 AstraZeneca PLC Recent Development 11.5 Pfizer, Inc
11.5.1 Pfizer, Inc Company Details
11.5.2 Pfizer, Inc Business Overview
11.5.3 Pfizer, Inc Anti-inflammatory Therapeutics Introduction
11.5.4 Pfizer, Inc Revenue in Anti-inflammatory Therapeutics Business (2016-2021)
11.5.5 Pfizer, Inc Recent Development 11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Anti-inflammatory Therapeutics Introduction
11.6.4 Novartis Revenue in Anti-inflammatory Therapeutics Business (2016-2021)
11.6.5 Novartis Recent Development 11.7 Roche
11.7.1 Roche Company Details
11.7.2 Roche Business Overview
11.7.3 Roche Anti-inflammatory Therapeutics Introduction
11.7.4 Roche Revenue in Anti-inflammatory Therapeutics Business (2016-2021)
11.7.5 Roche Recent Development 11.8 Merck
11.8.1 Merck Company Details
11.8.2 Merck Business Overview
11.8.3 Merck Anti-inflammatory Therapeutics Introduction
11.8.4 Merck Revenue in Anti-inflammatory Therapeutics Business (2016-2021)
11.8.5 Merck Recent Development 11.9 Sanofi
11.9.1 Sanofi Company Details
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Anti-inflammatory Therapeutics Introduction
11.9.4 Sanofi Revenue in Anti-inflammatory Therapeutics Business (2016-2021)
11.9.5 Sanofi Recent Development 11.10 GlaxoSmithKline
11.10.1 GlaxoSmithKline Company Details
11.10.2 GlaxoSmithKline Business Overview
11.10.3 GlaxoSmithKline Anti-inflammatory Therapeutics Introduction
11.10.4 GlaxoSmithKline Revenue in Anti-inflammatory Therapeutics Business (2016-2021)
11.10.5 GlaxoSmithKline Recent Development 11.11 Sun Pharmaceutical Industries Ltd
11.11.1 Sun Pharmaceutical Industries Ltd Company Details
11.11.2 Sun Pharmaceutical Industries Ltd Business Overview
11.11.3 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Introduction
11.11.4 Sun Pharmaceutical Industries Ltd Revenue in Anti-inflammatory Therapeutics Business (2016-2021)
11.11.5 Sun Pharmaceutical Industries Ltd Recent Development 11.12 TEVA
11.12.1 TEVA Company Details
11.12.2 TEVA Business Overview
11.12.3 TEVA Anti-inflammatory Therapeutics Introduction
11.12.4 TEVA Revenue in Anti-inflammatory Therapeutics Business (2016-2021)
11.12.5 TEVA Recent Development 12 Analyst’s Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details
About Us
QY Research is a leading global market research and consulting company. Established in 2007 QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and custom research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship and our strong commitment to sustainability. Today, we are serving more than 4000 clients across five continents. Let�s allow us to work closely with you and build a bold and a better future.
https://neighborwebsj.com/
